RYGRX
Price
$84.86
Change
+$1.48 (+1.78%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

RYGRX vs VIGIX

Header iconRYGRX vs VIGIX Comparison
Open Charts RYGRX vs VIGIXBanner chart's image
Rydex S&P 500 Pure Growth C
Price$84.86
Change+$1.48 (+1.78%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
RYGRX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYGRX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYGRX is a Buy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. RYGRX (35.1M). VIGIX pays higher dividends than RYGRX: VIGIX (0.53) vs RYGRX (0.00). RYGRX was incepted earlier than VIGIX: RYGRX (21 years) vs VIGIX (27 years). RYGRX is a more actively managed with annual turnover of: 434.00 vs. VIGIX (5.00). RYGRX has a lower initial minimum investment than VIGIX: RYGRX (2500) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. RYGRX (28.42). VIGIX return over 5 years is better than : 129.76 vs. RYGRX (43.49).
RYGRXVIGIXRYGRX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years27 years-
Gain YTD28.22634.27282%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets35.1M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year28.4234.3783%
Returns for 3 years-0.8132.77-2%
Returns for 5 years43.49129.7634%
Returns for 10 years71.37298.5824%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology